All Chordoma Sites
Showing 1 - 25 of >10,000
A Protocol to Identify Sporadic Chordoma Studies of
Recruiting
- Genes
- Sporadic Chordoma
-
Rockville, MarylandWestat, Inc.
Aug 20, 2022
Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),
Recruiting
- Non Small Cell Lung Cancer
- Chemotherapy
- +2 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 19, 2022
NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)
Active, not recruiting
- Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer Stage IV
- Durvalumab
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 21, 2022
Tumors at All Sites Which Will Receive Radiotherapy Trial in Amsterdam (radiotherapy)
Recruiting
- Tumors at All Sites Which Will Receive Radiotherapy
- radiotherapy
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Sep 22, 2022
Multiple Myeloma Trial in Multiple Locations (Routine care as per site standard.)
Recruiting
- Multiple Myeloma
- Routine care as per site standard.
-
Multiple Locations, GermanyMultiple sites all over germany
Aug 30, 2022
Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)
Not yet recruiting
- Oligometastatic Hormone Sensitive Prostate Cancer
- SBRT on all sites of metastatic disease+Apalutamide
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Jan 29, 2023
Appendicitis Trial in Istanbul (laparoscopic appendectomy port sites)
Completed
- Appendicitis
- laparoscopic appendectomy port sites
-
Istanbul, TurkeyFatih Sultan Mehmet Research and Training Hospital
Mar 19, 2021
Gene Biobank of Sports Injuries
Recruiting
- Gene Insertions
- Gene Deletion
-
Beijing, Beijing, ChinaInstitute of Sports Medicine, Peking University Third Hospital
Aug 6, 2021
Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)
Recruiting
- Chordoma
- Chemotherapy Effect
- camrelizumab and apatinib
-
Beijing, Beijing, ChinaBEIJING
Nov 14, 2023
Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)
Recruiting
- Ovarian Cancer
- +6 more
- Physician's choice according to patient's needs.
-
Multiple Locations, GermanyMultiple sites all over Germany
Dec 1, 2021
Chordoma of Spine, Surgery Trial (Resection surgery)
Not yet recruiting
- Chordoma of Spine
- Surgery
- Resection surgery
- (no location specified)
Jan 27, 2023
Hepatocellular Carcinoma (HCC), Cholangiocarcinoma Trial in Multiple Locations (Physician's choice according to patient's
Recruiting
- Hepatocellular Carcinoma (HCC)
- Cholangiocarcinoma
- Physician's choice according to patient's needs.
-
Multiple Locations, GermanyMultiple sites all over germany
Aug 27, 2021
Sacral Chordoma Trial in Heidelberg (protons, carbon ions)
Suspended
- Sacral Chordoma
- protons
- carbon ions
-
Heidelberg, GermanyUniversity of Heidelberg, Radiooncology, HIT
Nov 26, 2022
Multi-parametric Imaging in Personalized Radiotherapy
Recruiting
- Skull Base Chordoma
- diffusion MRI sequences
-
Pavia, Pv, ItalyCNAO
May 24, 2023
Chordoma, Metastatic Chordoma, Unresectable Chordoma Trial in Houston (Cetuximab, Questionnaire Administration)
Recruiting
- Chordoma
- +2 more
- Cetuximab
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jun 1, 2022
Chordoma Trial in Houston (Proton Beam Therapy, Photon Beam Therapy)
Active, not recruiting
- Chordoma
- Proton Beam Therapy
- Photon Beam Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Chordoma Trial in Baltimore, New York (other, biological, radiation)
Active, not recruiting
- Chordoma
- Laboratory Biomarker Analysis
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 3, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
(PRO) Registry in Patients With Advanced Renal Cell Carcinoma
Completed
- Renal Cell Carcinoma
-
Multiple Locations, GermanyMultiple sites all over Germany
Mar 24, 2021
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Skull Base Chordoma, Vertebral Chordoma Trial in Saint-Cloud (procedure, radiation, drug)
Active, not recruiting
- Skull Base Chordoma
- Vertebral Chordoma
- Surgery
- +2 more
-
Saint-Cloud, Ile De France, FranceInstitut Curie - Hôpital René Huguenin
Mar 30, 2022
Chordoma Trial in Worldwide (Randomized Cohort, Prospective cohort)
Recruiting
- Chordoma
- Randomized Cohort
- Prospective cohort
-
Graz, Austria
- +27 more
Oct 29, 2021